Cullinan Therapeutics Inc

XNAS:CGEM  
9.68
-0.30 (-3.01%)
7:51:43 PM EDT: $9.75 +0.07 (+0.72%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)554.65M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$6.25 Million
Adjusted EPS-$0.78
See more estimates
10-Day MA$10.57
50-Day MA$9.23
200-Day MA$8.09
See more pivots

Cullinan Therapeutics Inc Stock, XNAS:CGEM

One Main Street, Suite 1350, Cambridge, Massachusetts 02142
United States of America
Phone: +1.617.410.4650
Number of Employees: 111
http://cullinantherapeutics.com

Description

Cullinan Therapeutics, Inc. is a biopharmaceutical company engaged in developing oncology and immuno-oncology therapies. The company was founded by Patrick A. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.